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The antiproliferative and antioxidant activities of various extracts of the leaves of Bauhinia purpurea 
were studied using in vitro standard assays. The aqueous and chloroform extracts successfully 
inhibited the proliferation of all cancer cells while the methanol extract inhibited the proliferation of all 
cells except the CEMss cells when assessed using the 3,(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) (MTT) assay. The aqueous extract was effective against MCF-7 (IC50 ≈ 9 
µg/ml), MDA-MB 231 (IC50 ≈ 17 µg/ml) and Caov-3 (IC50 ≈ 16 µg/ml); the chloroform extract was highly 
effective against the CEMss (IC50 ≈ 18 µg/ml) and HeLa (IC50 ≈ 21 µg/ml); and the methanol extract was 
highly effective only against the HL-60 (≈ 12 µg/ml) cell lines. Interestingly, all extracts did not inhibit 
the proliferation of 3T3 cells suggesting their non-cytotoxic properties. The aqueous and methanol, but 
not chloroform, extracts of B. purpurea (20, 100 and 500 µg/ml) exhibited concentration-dependent 
antioxidant activity only in the superoxide scavenging assay, but low to moderate activity in the 2,2-
diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, which could be associated with their total 
phenolic contents. In conclusion, the B. purpurea leaf possesses potential antiproliferative and 
concentration-dependent antioxidant activities. Purification and determination of active compounds are 
required for further study. 
 





Herbal remedies are often sought by patients with chronic 
disease especially patients with cancers to provide symp-
tom relief (Saydah and Eberhardt, 2002; Barnes et al., 
2004; Mao et al., 2007). Barnes et al. (2004) have also 
reported that, natural product was one of the therapies 
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Abbreviations: ROS, Reactive oxygen species; MTT, 3,(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay; 
DMSO, dimethyl sulfoxide; FBS, fetal bovine serum; BHT, 
butylated hydroxytoluene; NBT, nitro blue tetrazolium; TPC, 
total phenolic content; NF-κB, nuclear factor-kappa B; NOS, 
nitric oxide synthase. 
Increase in death associated with cancer (Izevbigie, 2003), 
the callous side effects of some of the cancer chemo-
therapies (Humpel and Jones, 2006) and the recurrence 
of drug-resistant tumors as well as the lack of selectivity 
of anticancer drugs (Ferguson et al., 2004), have trig-
gered the search for more natural cancer fighting agents, 
particularly those derived from plants. The need for a 
continuous search for novel natural products that can act 
as cancer chemopreventive and/or chemotherapeutic 
agents, have triggered an increase in the interest on 
plant-derived secondary metabolites, with potential 
anticancer activity (Harborne, 2000). A variety of edible 
plants and compounds isolated from them have exerted 
anticancer activity.  
One of the plants that are currently under investigation 
in    our    laboratory     is     Bauhinia     purpurea   (family  




Leguminoseae). Known to the Malays as ‘pokok tapak 
kerbau’, B. purpurea is native to Southern China and India, 
and have been used to treat stomach tumors, ulcers, 
wounds, glandular swellings, diarrhea and fever (Zakaria 
et al., 2007). Scientifically, we have reported on the 
antinociceptive and anti-inflammatory activities of the 
aqueous extract of B. purpurea leaves and phytochemistry 
study has also revealed the presence of flavonoids, 
triterpenes, tannins and steroids (Zakaria et al., 2007). 
Different parts of B. purpurea contained kaempferol, 
quercetin and isorhamnetin (Salatino et al., 1999) 
havepacharin and bauhiniastatins 1-4 (Yadava and 
Tripathi, 2000) and dihydrodibenzoxepins (1-8), a 
dihydrobenzofuran, a novel spirochromane-2,1'-hexene-
dione and a new bibenzyl (Boonphong et al., 2007). 
Bauhiniastatins 1-4 were later found to exhibit anticancer 
activity against a minipanel of human cancer cell lines, 
including P388 lymphocytic leukemia cell line. Further-
more, Boonphong et al. (2007) demonstrated that, some 
of the isolated compounds exerted antimycobacterial, 
antimalarial, antifungal, cytotoxic and anti-inflammatory 
activities. Previous findings by Panda and Kar (1999) 
have demonstrated the ability of B. purpurea bark extract 
to stimulate thyroid function in female mice via increasing 
serum triiodothyronine (T3) and thyroxine (T4) concen-
trations as well as increasing the hepatic glucose-6-
phosphatase and antiperoxidative activities. Recent 
findings have revealed the ability of B. purpurea bark and 
leaf extracts to ameliorate metformin-induced hypo-
thyroidsm in Type II diabetic mice (Jatwa and Kar, 2009). 
In another study, it was shown to exhibit wound healing 
effect on experimentally induced excision, incision, burn 
and dead space wound models in Sprague Dawley rats 
(Ananth et al., 2010). In addition, Lakshmi et al. (2009) 
have also reported the potential of B. purpurea leaf and 
unripe pod to exert protective effects against gentamicin-
induced nephrotoxicity in rats. There are also patents 
related to B. purpurea wherein its lectin derivatives were 
used as larvicides against insects such as European corn 
borer (Rao et al., 1999). Wirth and Buchholz (2008) 
claimed that, the composition comprising an aqueous or 
hydroalcoholic extract of various types of Bauhinia, 
including B. purpurea are useful for care, preservation or 
improvement of the general state of the hair and skin, for 
prevention of human hair and skin ageing processes, and 
for the treatment of diseases associated with skin ageing. 
Reactive oxygen species (ROS) play important roles in 
the mechanisms of inflammation/pain, oxidation and 
cancers (Middleton et al., 2000). Inhibition of ROS has 
been claimed to be one of the mechanisms of anti-
inflammatory/antinociceptive, anticancer and antioxidant 
activities (Repetto and Llesuy, 2002). Based on these 
claims and our recent findings on the plant anti-
inflammatory and antinociceptive activities, the present 
study was designed to study the antiproliferative and 
antioxidant activities of the various extracts of B. purpurea 
using the 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-













The leaves of B. purpurea were collected in August to September 
2007 from their natural habitat in Shah Alam, Selangor, Malaysia 
and were identified by Mr. Shamsul Khamis, a botanist at the Institute 
of Bioscience (IBS), Universiti Putra Malaysia (UPM), Serdang, 
Selangor, Malaysia. A voucher specimen (SK 1095/05) has been 
deposited at the Herbarium of the Laboratory of Natural Products, 
Institute of Bioscience, UPM, Serdang, Selangor, Malaysia.  
 
 
Preparation of the aqueous, chloroform and methanol extracts 
of B. purpurea leaves 
 
The matured leaves of B. purpurea were air dried for 1 to 2 weeks 
at room temperature (27 ± 2°C) according to previous studies 
(Zakaria et al., 2006a; 2006b). The dried leaves were then grinded 
into small particles, weighed (40 g) and then sequentially soaked at 
room temperature for 72 h with distilled water (dH2O), chloroform 
and methanol in the ratio of 1:20 (w/v). Each of the mixture 
solutions were collected and filtered using Whatman No. 1 filter 
paper to obtained the aqueous, chloroform and methanol 
supernatants. The aqueous extracts of B. purpurea was kept at -
80°C for at least 48 h and then subjected to the freeze-drying 
process leading to a yield of 2.1 g (5.2%) of crude extracts, while 
the chloroform and methanol extracts of the plants were evaporated 
at 40°C under reduced pressure to dryness resulting in a yield of 
2.7 g (6.6%) and 1.1 g (2.7%), respectively. All the dried crude extracts 
obtained were kept at 4°C and prior to use, the aqueous extracts 
were dissolved in dH2O while the chloroform and methanol extracts 
were dissolved in 100% dimethyl sulfoxide (DMSO) to prepare the 
respective stock solutions (10 mg/ml). 
 
 
MTT assay  
 
All cell lines cultures of the American Type Culture Collection 
(ATCC), namely 3T3 (normal mouse fibroblast), MCF-7 (estrogen-
dependent human breast adenocarcinoma), MDA-MB-231 (human 
breast carcinoma), Caov-3 (human ovarian adenocarcinoma), HL-
60 (acute promyelocytic leukemia), CEMss (T-lymphoblastic leukemia) 
and HeLa (human cervical adenocarcinoma) were purchased from 
the American Type Culture Collection (ATCC; Rockville, MD) MCF-
7 and HT-29 were cultured in Roswell Park Memorial Institute 1640 
supplemented with 10% of fetal bovine serum (FBS), 100 IU/ml of 
penicillin and 100 µg/ml of streptomycin using 25 cm
2
 flasks, in 5% 
CO2 incubator at 37°C. The viability of cells was determined with 
trypan blue reagent. Exponentially growing cells were harvested, 
counted with haemocytometer and diluted with a particular medium. 
Cell culture with a concentration of 1 x 10
5
 cells/ml was prepared 
and plated (100 µl/well) onto 96 well plates (NUNCTM, Denmark). 
Prior to addition of cells onto the plates, the stock solution was 
diluted with media, transferred onto the wells and sequentially added 
with cells in media to achieve the required starting concentration of 
100 µg/ml in 1% DMSO. The concentration was serially diluted in 
each well to achieve concentration range of 100 - 12.5 µg/ml. The 
proliferative activity was determined using MTT assay (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (Abdullah 
Sani et al., 2004). The incubation period was 72 h. The spectro-
photometrical absorbance of the mammalian cell extract was 
measured  using  an  enzyme-linked  immunosorbent assay (ELISA)  






Figure 1. In vitro antiproliferative activity of the aqueous, chloroform and methanol extracts of B. 




reader at a wavelength of 550 nm after solubilization of the purple 
formazan crystals. Cytotoxicity was recorded as the drug 
concentration causing 50% growth inhibition of the tumour cells 
(IC50 value) using the formula given below:  
 
           OD sample (mean) 
% Cell viability =             × 100%
                              OD control (mean)  
 
Where, OD = optical density. 
 
After determining the percentage of cytotoxicity, graphs were 
plotted against its respective concentrations. In all the experiments, 
the antiproliferative assay was repeated three times with tamoxifen 





DPPH radical scavenging activity  
 
Assay for DPPH free radical scavenging potential was conducted 
using previous method with some modifications (Chen et al., 1999). 
Reaction mixtures containing test samples in methanol and 200 µM 
DPPH (Sigma) in ethanolic solution were incubated at 37°C for 30 
min in a 96 well microtiter plate. After the reaction, absorbance was 
then measured at 520 nm and percentage of inhibition was calculated. 
Butylated hydroxytoluene (BHT) was used as positive control. 
 
 
Superoxide anion radical scavenging activity  
 
The superoxide anion radical scavenging activity was performed 
using the method of Okamura et al. (1993) with some modifications. 
This assay is based on the rate of removal of xanthine/xanthine 
oxidase-generated  superoxide  by  measuring the reduction of nitro 
blue tetrazolium (NBT). The sample solution (0.1 mg/ml) in 5% 
DMSO was added to 1 ml of a mixture of 0.1 mM xanthine and 0.2 
mM NBT (Sigma, USA) in 50 mM potassium phosphate buffer (pH 
7.5) containing 0.05 mM EDTA. Xanthine oxidase (0.1 ml) (Sigma, 
USA; 0.8 unit/ml) diluted in 50 mM phosphate buffer (pH 7.5) was 
added and the resulting mixture was incubated at 37°C for 20 min. 
Addition of 2 ml of 2.5 N HCl to the mixtures terminated the reaction, 
followed by increase in the coloration of NBT, which was measured 
at 540 mM. The percentage of rate of superoxide removal by sam-




Phytochemical screening of the various extracts of the B. 
purpurea leaves 
 
Phytochemical screening was carried out on the aqueous, chloro-
form and methanol extracts of B. purpurea leaves according to the 
standard screening tests and conventional protocols as described 





DMSO alone did not inhibit proliferative activity of all the 
cell lines used in the present study, which is as indicated 
by its failure to produce the respective IC50 against all of 
the cell lines. The aqueous, chloroform and methanol 
extracts of B. purpurea leaves did not affect the percen-
tage of cells viability when tested against the normal cell 
line (3T3) (Figure 1). The percentages of viability of 3T3 
cells recorded were above 60%, indicating its non-toxic 
properties. 
Figure 2 shows the antiproliferative profiles of the 
aqueous,  chloroform  and methanol extracts of B. purpurea  






Figure 2. In vitro antiproliferative activity of the aqueous, chloroform and methanol extracts of B. 






Figure 3. In vitro antiproliferative activity of the aqueous, chloroform and methanol extracts of B. 




leaves against the MCF-7 cancer cell line. All extracts 
inhibited the proliferation of MCF-7 with the effective 
antiproliferative activity seen in the order of aqueous 
extract followed by the chlororform and methanol extracts. 
The IC50 values recorded for these extracts were 9, 23 
and 83 µg/ml, respectively.  
All extracts of B. purpurea leaves exhibited significant 
antiproliferative activity against the MDA-MB 231 cancer 
cell line as shown in Figure 3. The aqueous extract 
followed by the chloroform and methanol extracts exerted 
their activities at IC50 values of 17, 19 and 75 µg/ml, res-
pectively.  The  ability  of  the  aqueous,  c hloroform  and  






Figure 4. In vitro antiproliferative activity of the aqueous, chloroform and methanol extracts of Melastoma 






Figure 5. In vitro antiproliferative activity of the aqueous, chloroform and methanol extracts of 




methanol extracts of B. purpurea leaves to inhibit the 
proliferation of Caov-3 cancer cell lines is demonstrated 
in Figure 4. All extracts exhibited antiproliferative activity 
with the aqueous, followed by chloroform and methanol 
extracts produced IC50 values of 16, 25 and 41 µg/ml, 
respectively.  
Figure 5 shows the antiproliferative profile of the 
aqueous, chloroform and methanol extracts of B. purpurea 
leaves against the HL-60 cancer cell line. All extracts 
inhibited the proliferation of HL-60 cells with the methanol, 
aqueous, and chloroform extracts producing IC50 values 
of  12, 13 and 14 µg/ml, respectively. The antiproliferative  






Figure 6. In vitro antiproliferative activity of the aqueous, chloroform and methanol extracts 






Figure 7. In vitro antiproliferative activity of the aqueous, chloroform and methanol extracts of B. 




profile of the aqueous, chloroform and methanol extracts 
of B. purpurea leaves against the CEMss cancer cell line 
is shown in Figure 6. Only the chloroform and aqueous 
extracts of B. purpurea leaves exhibited antiproliferative 
activity against CEMss with the IC50 values of 18 and 63 
µg/ml, respectively.  
The effect of aqueous, chloroform and methanol 
extracts of B. purpurea leaves on the proliferative potential 
of HeLa cancer cell lines can be seen in Figure 7, where 
the chloroform extract followed by the aqueous and 
methanol extracts of B. purpurea were found to produce 
IC50 values of 21, 24 and 84 µg/ml, respectively.  




Table 1. Comparison of the IC50 values between tamoxifen and the B. purpurea extracts. 
 
Compound/extract 
IC50 values µmg/ml) 











B. purpurea extracts 
Aqueous ND 9 17 16 12 63 24 
Chloroform ND 23 19 25 13 18 21 
Methanol ND 83 75 41 14 ND 84 
 
ND, Not detected because the concentration of extracts/drugs required to exhibit IC50 value were above 100 µg/ml (the highest 
concentration used) 
a




Table 2. The antioxidant activity of the aqueous, chloroform and methanol extracts of the leaves of B. 
purpurea assessed by DPPH radical scavenging and superoxide scavenging assays. 
 







BHT 5 44.3 ± 0.6 - 
Quercetin 20 - 35.7 ± 1.3 
B. purpurea Aqueous 20 0.8 ± 0.4 26.1 ± 3.7 
100 6.1 ± 1.9 31.9 ± 1.5 
500 25.5 ± 0.6 89.4 ± 0.25 
 
Chloroform 
20 0.1 ± 0.1 17.5 ± 0.1 
100 8.6 ± 1.2 31.6 ± 1.8 
500 55.1 ± 1.2 61.6 ± 1.2 
 
Methanol 
20 3.2 ± 0.5 38.2 ± 0.5 
100 15.1 ± 0.2 15.1 ± 0.2 




Comparison of the antiproliferative activity of those 
extracts of B. purpurea leaves was made against tamoxifen 
using their IC50 values (Table 1). Generally, tamoxifen 
exhibited potent antiproliferative activity when compared 
against the respective extract as indicated by its lower 
IC50 values. 
Table 2 shows the antioxidant activities of the aqueous, 
chloroform and methanol extracts of B. purpurea assessed 
using the DPPH radical scavenging and superoxide 
dismutase scavenging assays. The 20, 100 and 500 
µg/ml of aqueous, chloroform and methanol extracts pro-
duced low to moderate DPPH radical scavenging activity 
with 0.7-25.0, 0.1-55.1 and 3.2-57.7%, respectively. The 
same extracts produced 26.1-89.4, 17.5-61.6 and 14.2-
88.1% of superoxide scavenging activity. The superoxide 
dismutase scavenging activity produced by 500 µg/ml 
aqueous and methanol extracts was considered high 
when compared with the chloroform extract. 
The total phenolic content (TPC) of the aqueous, 
chloroform and methanol extracts (2 and 10 mg/ml) were 
also determined (Table 3). The aqueous extract, at 2 and 
10 mg/ml, was found to contain the highest phenolic 
content, which contains approximately 2571 and 2073 
mg/100g of gallic acid, respectively. In addition, the 10 
mg/ml  methanol  extract  also  contain  considerably high 
total phenolic content (1023 mg/100 g gallic acid). 
Preliminary screening for phytochemical constituents in 
the aqueous, chloroform and methanol extracts of B. 
purpurea revealed the presence of different sets of com-
pounds in each of the extract (Table 4). The aqueous 
extract contained only saponins; the chloroform extract 
contained flavonoids and steroids; the methanol extract 





The present study demonstrated the antiproliferative 
activity of the aqueous, chloroform and methanol extracts 
of the leaves of B. purpurea against various panel of 
cancer cell lines. Interestingly, all extracts did not show 
any cytotoxic effect on the normal cell (3T3) indicating 
that they are safe. The aqueous and chloroform extracts 
were effective against all cancer cells with the former 
exhibiting the lowest IC50 value against MCF-7 (≈ 9 µg/ml), 
MDA-MB 231 (≈ 17 µg/ml) and Caov-3 (≈ 16 µg/ml), while 
the later was highly effective against the CEMss (≈ 18 
µg/ml) and HeLa (≈ 21 µg/ml) cell lines. The methanol 
extract was highly effective only against the HL-60 (≈ 12 
µg/ml).  




Table 3. The total phenolic content of the aqueous, chloroform and methanol extracts of the leaves 





Total phenolic content 






0.2 577.2 ± 0.5 
2 2073.2 ± 0.3* 
10 2570.7 ± 4.9* 
Chloroform 
0.2 63.2 ± 6.5 
2 165.7 ± 1.0 
10 405.0 ± 0.2 
Methanol 
0.2 220.6 ± 0.1 
2 762.5 ± 9.3 
10 1023.0 ± 1.1* 
 
Total phenolic content (TPC) , expressed as milligram equivalent of gallic acid per 100 g of dry weight 




Table 4. The phytochemical constituents of the aqueous, 
chloroform and methanol extracts of the leaves of B. purpurea. 
 
Constituents 
Extracts of M. malabathricum leaves 
Aqueous Chloroform Methanol 
Flavonoids - + + 
Triterpenes - - - 
Tannins - - - 
Alkaloids - - - 
Saponins + - + 




All extracts were also found to exhibit a low to 
moderate antioxidant activity when assessed using the 
DPPH radical scavenging assay. However, the aqueous 
and methanol extracts showed high antioxidant activity 
when assessed using the superoxide anion scavenging 
assay as indicated by the higher percentage of radical 
scavenging activity (< 80%). Generally, the antioxidant 
properties of these extracts were found to be concentration-
dependent. Based on the results obtained, the aqueous 
and methanol extracts, which are more polar solvent 
extracts, were more effective antioxidants compared to 
the non polar chloroform extract in both assays. This find-
ing is in conformity with the report by Chang et al. (2007).  
Studies on medicinal plants/herbs with high phenolic 
contents have gained importance over the past few years 
due to the high antioxidant (Zhu et al., 2004), anti-
inflammatory (Kim et al., 2004) and anti-carcinogenic 
activities (Yang et al., 2001), and are of great value in 
decreasing the risk of many human diseases. Further-
more, flavonoids and other phenolic compounds derived 
from plants demonstrated scavenging activity and thus, 
viewed as potential therapeutic drugs for free radical 
pathologies (Zhu et al., 2004). The antioxidative activities 
observed can be attributed to either the different mech-
anisms exhibited  by  different   polyphenolic  compounds 
that is, tocopherols, flavonoids and other organic acids 
and to the synergistic effects of different compounds. 
According to Huang et al. (2005), the antioxidant effect of 
these compounds could be attributed to the different 
functional properties carried by them, which includes: (1) 
The reactive oxygen species scavenging activity as seen 
with quercetin and catechin; (2) inhibition of the 
generation of free radicals and chain-breaking activity as 
seen with p-coumaric acids; (3) metal chelation activity. 
Determination of the total phenolic content showed that. 
the aqueous- followed by the methanol and chloroform-
extracts, contain the highest phenolic compounds. Although 
previous reports have correlated the high antioxidant 
activity to the presence of high total phenolic content 
(Yang et al., 2006), those findings were only in line with 
the results obtained with the superoxide dismutase 
scavenging assay, but not with the DPPH scavenging 
assay. However, it is believed that, the total phenolic 
contents of these extracts contribute to the low to moderate 
antioxidant activity when assessed using the latter assay. 
We have previously reported on the antinociceptive and 
anti-inflammatory activities of the aqueous extract of B. 
purpurea leaves assessed using various animal models 
(Zakaria et al., 2007). It is believed that, the free radical 
scavenging effects took part as one of the mechanisms 
through which the extracts of B. purpurea exhibited their 
anticancer activity in the present study and anti-
inflammatory activity as reported previously (Yang et al., 
2006). 
Taking into consideration the absence of flavonoid in 
the aqueous extract despite its high total phenolic con-
tent, the in vitro inhibition of cancer cell proliferation 
observed in the present study cannot be solely explained 
by the concentration of phenolic/flavonoid compounds. 
Other phytochemicals, particularly saponins and possibly 
non-flavonoid type of phenolic compounds may play a 
major role in the antiproliferative activity of the aqueous 
extracts (Huang et al., 2005; Lemeshko et al., 2006). The 





contribute partly to the antiproliferative activity observed 
through the antioxidant and free radical scavenging effects. 
Based on the bioactive compounds detected in those 
extracts, several possible antiproliferative mechanisms 
could be proposed. Saponins have been shown to cause 
necrotic cell death (Russo et al., 2005) or cell cycle 
disruption (Roy et al., 2007). In addition, Lee et al. (2006) 
have confirmed that, the disruption of the cell cycle 
activity was attained through the inhibition of nuclear 
factor-kappa B (NF-κB) or through the decreasing 
number of cells in G0/G1 phase followed by the initial 
increases in S and G2/M. Other than that, saponins were 
also reported to induce apoptosis through permeabilization 
of the mitochondrial membranes (Lemeshko et al., 2006). 
Flavonoids have been reported to: (1) Induce the Ca
2+
-
dependent apoptotic or the cyclin-dependent kinase 
inhibitors mechanisms; (2) modulate the cell cycle arrest 
at the G1/S phase; (3) inhibit the cell survival kinase and 
the inflammatory transcription factors; or (4) down 
regulate the anti-apoptotic gene products (Sergeev et al., 
2006). In addition, flavonoids also modulate the expression 
of pro-inflammatory gene of nitric oxide synthase (NOS) 
and cyclooxygenase-2 (COX-2) (Kim et al., 2004), 
signifying its capability to modulate the oxidative 
processes. In conclusion, the present study demonstrated 
that the B. purpurea leaves’ extracts possessed 
significant antiproliferative and antioxidant activities, which 
are somehow not attributed to their phenolics/flavonoids 
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